Results 181 to 190 of about 2,011,135 (332)

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Advanced Therapeutics, EarlyView.
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar, Weiwei Guo, Xin Shen, Yimeng Fang, Yilin Liu, Peng‐Yuan Wang, Roey Elnathan, Yaping Chen   +7 more
wiley   +1 more source

Cytotoxic interaction of virus specific effector cells with virus infected targets of different cell type [PDF]

, 1977
Ertl, Hildegund, Koszinowski, Ulrich H.
core   +1 more source

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

Journal of Virology, 1995
Yiping Yang, Qin Li, Hildegund C. J. Ertl, James M. Wilson   +3 more
semanticscholar   +1 more source

Multivalent mpox protein nanoparticle vaccines confer cross-protection against orthopoxvirus infection. [PDF]

PLoS Pathog
Zhang L, Liu C, Yang C, Xiao X, Xu S, Wan S, Xu K, Li Y, Dai L.   +8 more
europepmc   +1 more source

Enhanced Doxorubicin Cytotoxicity on Breast Cancer Spheroids by Aptamer Targeted Co‐Delivery with Hyaluronidase

Advanced Therapeutics, EarlyView.
Breast cancer is one of the most prevalent solid tumors in women. Doxorubicin is loaded mesoporous silica nanoparticles, capped with HER2‐specific aptamers, and the particle surface is functionalized with hyaluronidase. This dual‐functionalized nanocarrier system offers a promising solution for the drug resistance by solid tumors.
Murat Kavruk, Dide Su Demirel, Farzaneh Bonyadi, Buket Çakmak Güner, Ali Doğan Dursun, Cekdar Vakifahmetoglu, Bilge Güvenç Tuna, Uğur Şahin, Veli Cengiz Ozalp   +8 more
wiley   +1 more source

Proviruses in CD4⁺ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia. [PDF]

Sci Transl Med
Wu F, Moskovljevic M, Dragoni F, Jayaraman S, Board NL, Camilo-Contreras A, Bernal S, Hariharan V, Zhang H, Lai J, Singhal A, Poulin S, Chano F, Chamberland A, Tremblay C, Zoltick M, Hoffmann CJ, Jones JL, Larman HB, Montaner LJ, Siliciano JD, Siliciano RF, Simonetti FR.   +22 more
europepmc   +1 more source

Genetic Engineering Methods in Primary T Cells

Advanced Therapeutics, EarlyView.
Primary T cells can be engineered to confer them with novel therapeutic functions, allowing them to treat a variety of conditions. Genetic engineering can be either stable or transient, aiming to either express or inhibit a target gene. This review discusses the various genetic engineering tools available as well as their characteristics and ...
Anthony Youssef, Hui‐Shan Li
wiley   +1 more source

Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4+ T cells but are incapable of cross‐presentation

European Journal of Immunology, 2011
M. van der Vlist, L. D. de Witte, R. D. de Vries, M. Litjens, M. de Jong, D. Fluitsma, R. D. de Swart, T. Geijtenbeek   +7 more
semanticscholar   +1 more source

Understanding the Enigmatic Dance of Immune-Mediated Viral Infections and Their Pathogenetic Mechanisms. [PDF]

Vet Med Sci
Karabulut MC, Oğuzoğlu TÇ.
europepmc   +1 more source

T-cell recognition of infuenza viral antigens

Human Immunology, 1987
Andrew J. McMichael, Andrew J. McMichael, Jonathan R. Lamb, Jonathan R. Lamb, J Rothbard, J Rothbard   +5 more
openaire   +4 more sources